Yaoming biological response: the cdmo cooperation between the company and vir continues to return only the interests of vir covid-19 neutralizing antibody in Greater China

On May 21, in response to the rumor of "termination of the agreement between vir company and Yaoming biology", Yaoming biology CEO Chen Zhisheng responded in the wechat circle of friends: Yaoming biology has returned the Greater China rights and interests of vir covid-19 neutralizing antibody, but all vir cdmo projects have not changed and continue to be developed and produced in the company; When covid-19 epidemic broke out in 2020, Yaoming biological cooperated with vir and obtained the rights and interests of Greater China of vir covid-19 neutralizing antibody in view of the sense of corporate social responsibility; At present, covid-19 epidemic has been basically controlled, so the company has returned relevant rights and interests.